Sentinel node biopsy for breast cancer: Showtime or dress rehearsal?

Frederick L Moffat, Takamaru Ashikaga, David N. Krag

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction: Sentinel lymph node biopsy (SLNB) may prove superior to axillary node dissection (AND) for breast cancer staging. At issue is whether existing clinical data support performance of SLNB without AND at this time. Discussion: The various methods of SLNB are discussed in detail. SLNB using radiocolloids and surgical probes (with or without blue dye) yields superior SLN localization rates as compared to blue dye alone. However, the incidence of false-negative SLNB is variable with all methods and frequently 10% or higher (11.4% in the only published multicenter study). Conclusions: Outside of a clinical trial, SLNB should be performed in addition to, not instead of, AND. The sensitivity of pathological staging is enhanced and nonaxillary SLNs are identified, while concomitant AND apprehends all false-negative SLNBs. Two prospective randomized cooperative trials provide excellent educational, training and research opportunities for North American breast surgeons as they gain experience with this new, promising staging procedure.

Original languageEnglish
Pages (from-to)255-264
Number of pages10
JournalIn Vivo
Volume14
Issue number1
StatePublished - Jan 1 2000

Fingerprint

Sentinel Lymph Node Biopsy
Biopsy
Dissection
Breast Neoplasms
Coloring Agents
Neoplasm Staging
Multicenter Studies
cyhalothrin
Breast
Clinical Trials
Incidence
Research

Keywords

  • Gamma detection probes
  • Isosulfan blue dye
  • Lymphoscintigraphy
  • Radiocolloids
  • Sentinel lymph node biopsy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sentinel node biopsy for breast cancer : Showtime or dress rehearsal? / Moffat, Frederick L; Ashikaga, Takamaru; Krag, David N.

In: In Vivo, Vol. 14, No. 1, 01.01.2000, p. 255-264.

Research output: Contribution to journalArticle

Moffat, FL, Ashikaga, T & Krag, DN 2000, 'Sentinel node biopsy for breast cancer: Showtime or dress rehearsal?', In Vivo, vol. 14, no. 1, pp. 255-264.
Moffat, Frederick L ; Ashikaga, Takamaru ; Krag, David N. / Sentinel node biopsy for breast cancer : Showtime or dress rehearsal?. In: In Vivo. 2000 ; Vol. 14, No. 1. pp. 255-264.
@article{040c6d2cd04446bf9940ea71e2ac422a,
title = "Sentinel node biopsy for breast cancer: Showtime or dress rehearsal?",
abstract = "Introduction: Sentinel lymph node biopsy (SLNB) may prove superior to axillary node dissection (AND) for breast cancer staging. At issue is whether existing clinical data support performance of SLNB without AND at this time. Discussion: The various methods of SLNB are discussed in detail. SLNB using radiocolloids and surgical probes (with or without blue dye) yields superior SLN localization rates as compared to blue dye alone. However, the incidence of false-negative SLNB is variable with all methods and frequently 10{\%} or higher (11.4{\%} in the only published multicenter study). Conclusions: Outside of a clinical trial, SLNB should be performed in addition to, not instead of, AND. The sensitivity of pathological staging is enhanced and nonaxillary SLNs are identified, while concomitant AND apprehends all false-negative SLNBs. Two prospective randomized cooperative trials provide excellent educational, training and research opportunities for North American breast surgeons as they gain experience with this new, promising staging procedure.",
keywords = "Gamma detection probes, Isosulfan blue dye, Lymphoscintigraphy, Radiocolloids, Sentinel lymph node biopsy",
author = "Moffat, {Frederick L} and Takamaru Ashikaga and Krag, {David N.}",
year = "2000",
month = "1",
day = "1",
language = "English",
volume = "14",
pages = "255--264",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - Sentinel node biopsy for breast cancer

T2 - Showtime or dress rehearsal?

AU - Moffat, Frederick L

AU - Ashikaga, Takamaru

AU - Krag, David N.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Introduction: Sentinel lymph node biopsy (SLNB) may prove superior to axillary node dissection (AND) for breast cancer staging. At issue is whether existing clinical data support performance of SLNB without AND at this time. Discussion: The various methods of SLNB are discussed in detail. SLNB using radiocolloids and surgical probes (with or without blue dye) yields superior SLN localization rates as compared to blue dye alone. However, the incidence of false-negative SLNB is variable with all methods and frequently 10% or higher (11.4% in the only published multicenter study). Conclusions: Outside of a clinical trial, SLNB should be performed in addition to, not instead of, AND. The sensitivity of pathological staging is enhanced and nonaxillary SLNs are identified, while concomitant AND apprehends all false-negative SLNBs. Two prospective randomized cooperative trials provide excellent educational, training and research opportunities for North American breast surgeons as they gain experience with this new, promising staging procedure.

AB - Introduction: Sentinel lymph node biopsy (SLNB) may prove superior to axillary node dissection (AND) for breast cancer staging. At issue is whether existing clinical data support performance of SLNB without AND at this time. Discussion: The various methods of SLNB are discussed in detail. SLNB using radiocolloids and surgical probes (with or without blue dye) yields superior SLN localization rates as compared to blue dye alone. However, the incidence of false-negative SLNB is variable with all methods and frequently 10% or higher (11.4% in the only published multicenter study). Conclusions: Outside of a clinical trial, SLNB should be performed in addition to, not instead of, AND. The sensitivity of pathological staging is enhanced and nonaxillary SLNs are identified, while concomitant AND apprehends all false-negative SLNBs. Two prospective randomized cooperative trials provide excellent educational, training and research opportunities for North American breast surgeons as they gain experience with this new, promising staging procedure.

KW - Gamma detection probes

KW - Isosulfan blue dye

KW - Lymphoscintigraphy

KW - Radiocolloids

KW - Sentinel lymph node biopsy

UR - http://www.scopus.com/inward/record.url?scp=0343184007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343184007&partnerID=8YFLogxK

M3 - Article

C2 - 10757084

AN - SCOPUS:0343184007

VL - 14

SP - 255

EP - 264

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 1

ER -